Page last updated: 2024-09-03

ginsenoside rh2 and Cardiotoxicity

ginsenoside rh2 has been researched along with Cardiotoxicity in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cui, C; Hou, J; Kim, S; Yun, Y1

Other Studies

1 other study(ies) available for ginsenoside rh2 and Cardiotoxicity

ArticleYear
Ginsenoside Rh2 mitigates doxorubicin-induced cardiotoxicity by inhibiting apoptotic and inflammatory damage and weakening pathological remodelling in breast cancer-bearing mice.
    Cell proliferation, 2022, Volume: 55, Issue:6

    Topics: Animals; Apoptosis; Breast Neoplasms; Cardiotoxicity; Doxorubicin; Endothelial Cells; Female; Ginsenosides; Humans; Mice; Mice, Nude; Myocytes, Cardiac; Necrosis; Oxidative Stress; RNA

2022